TSX/PRN (TSX/PRN)

Toronto Stock Exchange: TSX/PRN · CAD

CA$8.18

+0.09 (+1.1%)· Recorded snapshot

Market cap	298.8M
Revenue (ttm)	27.1M
Net income (ttm)	-46.5M
EPS (ttm)	-CA$1.39
Shares out	36.5M
Volume	1,302
Beta	0.55

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 27.1M
Net income (ttm): -46.5M
EPS (ttm): -CA$1.39
Market cap: 298.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-73.5

P25 n/aP50 n/aP75 n/a

ROIC-43.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/PRN indicators

Market & fundamental data

Available fields

189

Groups with data

Currency

USD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-05
Employees	162
Employees change	20
Employees growth	14.08%
Enterprise value	CAD 255M
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Industry	Medical Devices
Is primary listing	Yes
ISIN number	CA74319B5027
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Last stock split date	2019-10-16
Last stock split type	Reverse
Market cap	CAD 298.8M
Next earnings date	2026-11-05
Price	CAD 8.18
Price currency	CAD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-29
Symbol	tsx/PRN
Website	https://www.profoundmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-17.04%
EV/Sales	9.29x
FCF / EV yield	-20.47%
FCF yield	-17.43%
P/B ratio	4.18x
P/S ratio	10.9x
Price / tangible book value	4.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-185.31%
EBITDA margin	-182.74%
Gross margin	71.79%
Operating margin	-185.31%
Pretax margin	-170.37%
Profit margin	-171.56%
Profit per employee	CAD -287,036
Revenue per employee	CAD 167,309
ROA	-39.46%
ROA (5Y)	-29.68%
ROCE	-66.39%
ROE	-73.53%
ROE (5Y)	-54.72%
ROIC	-43.66%
SBC / revenue	26.05%
Tax / revenue	1.19%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	66.66%
Gross profit growth (Q)	20.33%
Gross profit growth 3Y	52.1%
Gross profit growth 5Y	27.39%
Net income growth quarters	2
Net income growth years	0
Revenue growth	61.2%
Revenue growth (Q)	12.3%
Revenue growth (QoQ)	-53.48%
Revenue growth 3Y	41.38%
Revenue growth 5Y	17.68%
Revenue growth quarters	4
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -249,938
Depreciation and amortization	CAD 687,049
EBIT	CAD -50.2M
EBITDA	CAD -49.5M
EPS	CAD -1.39
FCF per share	CAD -1.41
Financing cash flow	CAD 58.8M
Free cash flow	CAD -51.5M
Free cash flow minus SBC	CAD -58.6M
Gross profit	CAD 19.5M
Income taxes	CAD 322,363
Investing cash flow	CAD -343,664
Net cash flow	CAD 4.4M
Net income	CAD -46.5M
Operating cash flow minus SBC	CAD -58.3M
Operating income	CAD -50.2M
Revenue	CAD 27.1M
Stock-based compensation	CAD 7.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.63
Book value per share	CAD 1.94
Debt / equity	0.15
Long-term assets	CAD 6.2M
Long-term liabilities	CAD 5.1M
Net cash (debt)	CAD 43.9M
Net cash / market cap	14.84%
Net cash growth	1.68%
Net debt / equity	-0.62
Piotroski F-Score	2
Property, plant and equipment	CAD 4.6M
Shareholders' equity	CAD 70.7M
Tangible book value	CAD 70.6M
Tangible book value per share	CAD 1.93
Total assets	CAD 88.6M
Total cash	CAD 54.3M
Total debt	CAD 10.5M
Total liabilities	CAD 17.9M
WACC	7.05%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.34
Current assets	CAD 82.4M
Current liabilities	CAD 12.8M
Current ratio	6.46
Inventory turnover	0.57
Net working capital	CAD 22.9M
Quick ratio	5.25
Working capital	CAD 70.7M
Working capital turnover	0.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-20.87%
Shareholder yield	-20.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-24.26%
10Y return CAGR	-2.74%
10Y total return	-24.26%
150-day SMA	CAD 9.27
1D price change	1.11%
1M price change	-2.73%
1M total return	-2.73%
1W price change	1.87%
1W total return	1.87%
1Y price change	-5.43%
1Y return CAGR	-5.44%
1Y total return	-5.43%
20-day SMA	CAD 8.56
200-day SMA	CAD 9.28
3M price change	-20.35%
3M total return	-20.35%
3Y price change	-27.22%
3Y return CAGR	-10.05%
3Y total return	-27.22%
50-day SMA	CAD 8.73
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 12.40
52-week high date	2026-01-13
52-week low	CAD 6.52
52-week low date	2026-03-09
5Y price change	-51.08%
5Y return CAGR	-13.32%
5Y total return	-51.08%
6M price change	-10.8%
6M total return	-10.8%
All-time high	CAD 36.73
All-time high date	2021-02-08
All-time low	CAD 4.21
All-time low date	2022-10-26
Average true range (ATR)	CAD 0.46
Average volume	14.5K
Beta (1Y)	2.27
Beta (2Y)	1.74
Beta (5Y)	0.55
Change from 52-week high	-34.03%
Change from 52-week low	25.46%
Change from all-time high	-77.73%
Change from all-time low	94.3%
Change from open	-0.12%
Day's gap	1.24%
Dollar volume	CAD 10,650
High price	CAD 8.31
Low price	CAD 8.17
Monthly RSI	44.26
Open price	CAD 8.19
Position in 52-week range	7.14%
Previous close	CAD 8.09
Price vs 150-day SMA	-11.77%
Price vs 20-day SMA	-4.43%
Price vs 200-day SMA	-11.88%
Price vs 50-day SMA	-6.28%
Relative volume	0.09
RSI	45.34
Sharpe ratio	0.37
Sharpe ratio (3Y)	0.05
Sharpe ratio (5Y)	0.05
Sortino ratio	0.62
Sortino ratio (3Y)	0.16
Sortino ratio (5Y)	0.16
Volume	1.3K
Weekly RSI	44.23
YTD price change	-24.05%
YTD total return	-24.05%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35.5M
Shares change (QoQ)	0.15%
Shares change (YoY)	20.87%
Shares held by insiders	2.82%
Shares held by institutions	50.57%
Shares outstanding	36.5M

Deeper analysis on TSX/PRN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/PRN report

Is a complete TSX/PRN research report available?

No complete published report is available for tsx/PRN (TSX/PRN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/PRN (TSX/PRN)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/PRN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/PRN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/PRN

Frequently asked questions